Evidence map›Paper›PMID 30922304›Full record

Observational studyMalaria journal2019

Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands.

Yi Wan Quah, Andreea Waltmann, Stephan Karl, Michael T White, Ventis Vahi, Andrew Darcy, Freda Pitakaka, Maxine Whittaker, Daniel J Tisch, Alyssa Barry and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Asymptomatic/submicroscopicParasite epidemiology and control · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yi Wan QuahPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Andreea WaltmannPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Stephan KarlPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Michael T WhiteDepartment of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
Ventis VahiNational Health Training & Research Institute, Ministry of Health, Honiara, Solomon Islands.
Andrew DarcyNational Health Training & Research Institute, Ministry of Health, Honiara, Solomon Islands.
Freda PitakakaNational Health Training & Research Institute, Ministry of Health, Honiara, Solomon Islands.
Maxine WhittakerCollege of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia.
Daniel J TischCase Western Reserve University, Cleveland, OH, USA.
Alyssa BarryPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Celine BarnadasPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
James KazuraCase Western Reserve University, Cleveland, OH, USA.
Ivo MuellerPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. mueller@wehi.edu.au.ORCID http://orcid.org/0000-0001-6554-6889

Funding

TransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ZIMMERMAN, PETER A. · 2010 to 2016
$9.9M
Understanding, tracking and eliminating malaria transmission in the Asia - Pacific RegionU19AI129392 · NIAID · WALTER AND ELIZA HALL INST MEDICAL RES · PI Ivo J Mueller, Leanne Robinson · 2017 to 2026
$7.1M
Kruppel-Like Factor 2 Counters Vascular and Immunologic Dysfunction in Child Cerebral MalariaR01AI130131 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2017 to 2021
$3.0M
National Health and Medical Research Council 1003825National Health and Medical Research Council 1043345National Health and Medical Research Council 1052760National Health and Medical Research Council 1092789National Health and Medical Research Council 1102297National Institute of Allergy and Infectious Diseases 1 U19 AI089686-01National Institute of Allergy and Infectious Diseases 1 U19 AI129392-01NIAID NIH HHS R01 AI130131NIAID NIH HHS U19 AI089686NIAID NIH HHS U19 AI129392University of Melbourne Melbourne International Postgraduate ScholarshipUniversity of Melbourne Melbourne International Research Scholarship
6 · The paper itself

Abstract

backgroundFollowing the scale-up of intervention efforts, malaria burden has decreased dramatically in Solomon Islands (SI). Submicroscopic and asymptomatic Plasmodium vivax infections are now the major challenge for malaria elimination in this country. Since children have higher risk of contracting malaria, this study investigated the dynamics of Plasmodium spp. infections among children including the associated risk factors of residual P. vivax burden.

methodsAn observational cohort study was conducted among 860 children aged 0.5-12 years in Ngella (Central Islands Province, SI). Children were monitored by active and passive surveillances for Plasmodium spp. infections and illness. Parasites were detected by quantitative real-time PCR (qPCR) and genotyped. Comprehensive statistical analyses of P. vivax infection prevalence, molecular force of blood stage infection (

resultsPlasmodium vivax infections were common (overall prevalence: 11.9%), whereas Plasmodium falciparum infections were rare (0.3%) but persistent. Although children acquire an average of 1.1 genetically distinct P. vivax blood-stage infections per year, there was significant geographic heterogeneity in the risks of P. vivax infections across Ngella (prevalence: 1.2-47.4%, p < 0.01;

conclusionResidual malaria transmission in Ngella exhibits strong heterogeneity and is characterized by a high proportion of submicroscopic and asymptomatic P. vivax infections, alongside sporadic P. falciparum infections. Implementing an appropriate primaquine treatment policy to prevent P. vivax relapses and specific targeting of control interventions to high risk areas will be required to accelerate ongoing control and elimination activities.

Indexed as

Disease Transmission, InfectiousGenotypeAge FactorsAsymptomatic InfectionsChildChild, PreschoolCohort StudiesFemaleGenotyping TechniquesHumansIncidenceInfantMalaria, FalciparumMalaria, VivaxMaleMelanesiaAsymptomaticCohortHeterogeneityPlasmodium vivaxSolomon Islands

Identifiers

PMID30922304
PMCPMC6437916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.